dc.contributorUniversidade Estadual Paulista (Unesp)
dc.contributorChaim Sheba Med Ctr
dc.date.accessioned2014-12-03T13:10:55Z
dc.date.available2014-12-03T13:10:55Z
dc.date.created2014-12-03T13:10:55Z
dc.date.issued2014-05-01
dc.identifierLupus. London: Sage Publications Ltd, v. 23, n. 6, p. 577-587, 2014.
dc.identifier0961-2033
dc.identifierhttp://hdl.handle.net/11449/112638
dc.identifier10.1177/0961203314527369
dc.identifierWOS:000334824800009
dc.identifier4977572416129527
dc.description.abstractRheumatoid arthritis (RA) is a chronic inflammatory autoimmune disease that is mainly directed to the joints, affecting the synovial membrane, the cartilage and also the bone. This disease affects 1% to 2% of the world population and is associated with significant morbidity and increased mortality. RA experimental models have allowed a great deal of information to be translated to the corresponding human disease. This review summarizes some of the most relevant findings targeting immunomodulation in arthritis. Some general guidelines to choose an adequate experimental model and also our experience with arthritis are supplied.
dc.languageeng
dc.publisherSage Publications Ltd
dc.relationLupus
dc.relation2.969
dc.relation1,410
dc.rightsAcesso restrito
dc.sourceWeb of Science
dc.subjectRheumatoid arthritis
dc.subjectvitamin D
dc.subjectdendritic cells
dc.subjecthelminths
dc.subjectregulatory T cells
dc.subjectheat-shock proteins
dc.titleImmunomodulation in human and experimental arthritis: including vitamin D, helminths and heat-shock proteins
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución